Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children&apos;s Oncology Group Study AREN0533

Central Nervous System Tumors

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group

Neuro Oncol

Mazewski C, Leary SES, Kang G, Li BK, Kellie S, Hayes L, Shaw D, Ho B, Reddy A, Gossett J, Burger PC, Judkins AR, Aridgides P, Geyer JR, Gajjar A, Pollack IF, Fouladi M, Huang A

doi: 10.1093/neuonc/noaf132

Sarcoma

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement

J Natl Compr Canc Netw

Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM

doi: 10.6004/jnccn.2024.7063

Central Nervous System Tumors

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

J Clin Oncol

Berko ER, Naranjo A, Daniels AA, McNulty SN, Krytska K, Druley T, Zelley K, Koneru B, Chen L, Polkosnik G, Irwin MS, Bagatell R, Maris JM, Reynolds CP, DuBois SG, Park JR, Mossé YP

doi: 10.1200/JCO-24-02407

Further Publications

The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)

Br J Haematol

Baccelli F, Compagno F, Tridello G, Delle Cave F, Zama D, Masetti R, Petris MG, Chiusaroli L, Spadea M, Trevisan F, Colombini A, Conci S, Meazza C, Muggeo P, Micheletti MV, Pancaldi A, Mura R, Onofrillo D, De Santis R, La Spina M, Castagnola E, Perruccio K, Barone A, Giurici N, Petrone A, Mercolini F, Rinieri S, Cesaro S

doi: 10.1111/bjh.70036

Breast Cancer

Clinical and patient-reported outcomes after oncoplastic versus conventional breast conserving surgery-a longitudinal, multicenter cohort study

J Natl Cancer Inst

Bargon CA, Mink Van Der Molen DR, Young-Afat DA, Batenburg MCT, Van Dam IE, Baas IO, Ernst MF, Maarse W, Sier MF, Schoenmaeckers EJP, Burgmans JPJ, Bijlsma RM, Siesling S, Rakhorst HA, Mureau MA, Van Der Leij F, Doeksen A, Verkooijen HM, UMBRELLA Study Group

doi: 10.1093/jnci/djae310

Breast Cancer

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies

Int J Cancer

García-Saenz JA, Spera G, Pollán M, Bermejo B, Ruiz-Borrego M, Chan A, Martín M, Guerrero-Zotano Á, Calvo L, Rodríguez-Lescure Á, Marín M, Chap L, Crown J, Pienkowski T, Bee V, Casas M, Polonio Ó, Bezares S, Slamon D

doi: 10.1002/ijc.35432

Genitourinary Cancer

Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

J Natl Compr Canc Netw

Balis F, Green DM, Armstrong A, Aye J, Benedetti D, Brown B, Brown E, Cook S, Desai A, Dhillon J, Fair D, Geynisman DM, Hiniker S, Horst K, Jasty-Rao R, Just M, Kieran K, Lin C, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Pinto N, Ranalli M, Rhee D, Rokitka D, Walz A, Wickiser J, Yoon J, Zapala M, Montgomery S, Sliker B

doi: 10.6004/jnccn.2025.0037

Multiple Myeloma (MM)

Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes

Blood

Freeman CL, Noble J, Menges M, Villanueva R, Nakashima JY, Figura NB, Tonseth RP, Idiaquez DW, Skelson L, Smith EC, Abraham-Miranda J, Corallo S, De Avila G, Castaneda Puglianini O, Liu HD, Alsina M, Nishihori T, Shain KH, Baz RC, Blue BJ, Grajales-Cruz A, Koomen JM, Atkins RM, Hansen DK, Siqueira Silva A, Kim J, Balagurunathan Y, Locke FL

doi: 10.1182/blood.2024024965

Central Nervous System Tumors

Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study

Neuro Oncol

Wach J, Basaran AE, Vychopen M, Tihan T, Wostrack M, Butenschoen VM, Meyer B, Siller S, Schmidt NO, Onken J, Vajkoczy P, Santos AN, Rauschenbach L, Dammann P, Sure U, Klingler JH, Doria-Medina R, Beck J, Blaß BI, Gizaw CJ, Hohenhaus R, Krieg S, Alhalabi OT, Klein L, Thomé C, Kögl N, Kunert P, Czernicki T, Pantel T, Middelkamp M, Eicker SO, Kattaa AH, Park DJ, Chang SD, Kilinc F, Czabanka M, Güresir E

doi: 10.1093/neuonc/noaf041

Oncology · Hematology

Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533

Related content

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)

Clinical and patient-reported outcomes after oncoplastic versus conventional breast conserving surgery-a longitudinal, multicenter cohort study

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies

Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes

Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study